Acute renal failure due to mantle cell lymphoma - A case report and discussion of the literature

Clinical Nephrology

Volumn 67, Issue 6, 2007, Pages 394-396

  Davies, J ^a   Healey, D A ^b   Wood, K M ^b   Jones, K ^b   Kanagasundaram, N S ^b  

^a ROYAL LIVERPOOL AND BROADGREEN UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^b FREEMAN HOSPITAL   (United Kingdom)

Author keywords

Acute renal failure; Mantle cell lymphoma (MCL); Thalidomide

Indexed keywords

CHLORAMBUCIL; CYTOTOXIC AGENT; DEXAMETHASONE; METHYLPREDNISOLONE; THALIDOMIDE;

ACUTE KIDNEY FAILURE; AGED; ANEMIA; ARTICLE; BLOOD TRANSFUSION; CANCER GRADING; CANCER RECURRENCE; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; DRUG EFFICACY; DRUG SAFETY; ECHOGRAPHY; EXOPHTHALMOS; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY BIOPSY; KIDNEY CANCER; LABORATORY TEST; MALE; MANTLE CELL LYMPHOMA; NEUTROPENIA; RENOGRAPHY; RETREATMENT; TREATMENT DURATION;

EID: 34250166918     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CNP67394     Document Type: Article

References (11)

1. Argatoff LH, Connors JM, Klasa RJ, Horsman DE, Gascoyne RD. Mantle cell lymphoma: a clinicopathologic study of 80 cases. Blood. 1997; 6: 2067-2078.
2. Da'as N, Polliack A, Cohen Y, Amir G, Darmon D, Kleinman Y, Goldfarb AW, Ben-Yehuda D. Kidney involvement and renal manifestations in non-Hodgkin's lymphoma and lymphocytic leukaemia: a retrospective study in 700 patients. Eur J Haematol. 2001; 67: 158-164.
3. Damaj G, Lefrere F, Delarue R et al. Thalidomide therapy induces response in relapsed mantle cell lymphoma. Leukaemia. 2003; 17: 1914-1915.
4. Fisher RI, Miller TP, O'Conner OA. Emerging new strategies in the treatment of mantle cell lymphoma. Haematology. 2004; 1: 221-236.
5. Jaffe ES, Harris NL, Stain H, Vardiman JW. World Health Organisation classification of tumours. Pathology and genetics of turnouts of haematopoietic and lymphoid tissues. Lyon: IARC Press; 2001. pp 168.
6. Kaufmann H, Raderer M, Wohrer S, Puspok A, Bankier A, Zielinski C, Chott A, Drach J. Antitumor activity of rituximab plus thalidomide in patients with relapsed/refractory mantle cell lymphoma. Blood. 2004; 104: 2269-2271.
7. McGivney WT et al. Practice Guidelines in Oncology - 2.2006. National Comprehensive Cancer Network, Inc: Mantle Cell Lymphoma. 2006. pp MANTI-2.
8. Obrador GT, Price B, O'Meara Y, Salant DJ. Acute renal failure due to lymphomatous infiltration of the kidneys. J Am Soc Nephrol. 1997; 8: 1348-1354.
9. Pro B, Younes A, Albitar M, Dang NH, Samaniego F, Romaguera J, McLaughlin P, Hagemeister FB, Rodriguez M, Clemons M, Cabanillas F. Thalidomide for patients with recurrent lymphoma. Cancer. 2004; 100: 1186-1189.
10. Sellin L, Friedl C, Klein G, Waldherr R, Rump C, Weiner S. Acute renal failure due to malignant lymphoma infiltration uncovered by renal biopsy. Nephrol Dial Transplant. 2004; 19: 2657-2660.
11. Tornroth T, Heiro M, Marcussen N, Franssila K. Lymphomas diagnosed by percutaneous kidney biopsy. Am J Kidney Dis. 2003; 42: 960-971.